| pubmed-article:8201373 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C1527249 | lld:lifeskim |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C0063067 | lld:lifeskim |
| pubmed-article:8201373 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:8201373 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:8201373 | pubmed:dateCreated | 1994-7-1 | lld:pubmed |
| pubmed-article:8201373 | pubmed:abstractText | Hydrazine sulfate is a controversial agent that was originally studied in cancer patients approximately 20 years ago. Based on a series of recent trials that suggested that this drug might have utility in cancer patients, we conducted this study. | lld:pubmed |
| pubmed-article:8201373 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8201373 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8201373 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8201373 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8201373 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8201373 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:O'FallonJ RJR | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:CobauC DCD | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:GoldbergR MRM | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:GerstnerJ BJB | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:LoprinziC LCL | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:RospondR MRM | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:GesmeD HDHJr | lld:pubmed |
| pubmed-article:8201373 | pubmed:author | pubmed-author:KurossS ASA | lld:pubmed |
| pubmed-article:8201373 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8201373 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:8201373 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8201373 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8201373 | pubmed:pagination | 1121-5 | lld:pubmed |
| pubmed-article:8201373 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:meshHeading | pubmed-meshheading:8201373-... | lld:pubmed |
| pubmed-article:8201373 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8201373 | pubmed:articleTitle | Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. | lld:pubmed |
| pubmed-article:8201373 | pubmed:affiliation | Mayo Clinic, Rochester, MN 55905. | lld:pubmed |
| pubmed-article:8201373 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8201373 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8201373 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8201373 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8201373 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8201373 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8201373 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8201373 | lld:pubmed |
